Clinical trials
Terminated Lymphoma, Non-Hodgkin trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2019 | 3 |
| 2021 | 4 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Incyte Corporation | 2 |
| MEI Pharma, Inc. | 2 |
| Novartis Pharmaceuticals | 2 |
| miRagen Therapeutics, Inc. | 2 |
| Bayer | 1 |
| Boehringer Ingelheim | 1 |
| Celgene | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Hoffmann-La Roche | 1 |
| Janssen Research & Development, LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Non-Hodgkin | 21 |
| Lymphoma | 7 |
| Lymphoma, Follicular | 5 |
| Lymphoma, Large B-Cell, Diffuse | 5 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 4 |
| Lymphoma, B-Cell, Marginal Zone | 4 |
| Lymphoma, T-Cell | 4 |
| Lymphoproliferative Disorders | 4 |
| Multiple Myeloma | 4 |
| Hodgkin Disease | 3 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.